Executive Committee
About the Executive Committee
Roche’s executive team is the company's senior management and decision making body. The Executive Committee of Roche, chosen by the Board of Directors, is responsible for the day-to-day business operations.
Corporate Executive Committee
| Name (year of birth) | Position | Member of the CEC since |
|---|---|---|
| Dr Thomas Schinecker (1975) | Chief Executive Officer Roche Group | 2019 |
| Teresa Graham (1973) | CEO Roche Pharmaceuticals | 2023 |
| Matt Sause (1977) | CEO Roche Diagnostics | 2023 |
| Dr Alan Hippe (1967) | Chief Financial Officer | 2011 |
| Cristina A. Wilbur (1967) | Chief People Officer | 2016 |
Enlarged Corporate Executive Committee
| Name (year of birth) | Position | Member of the enlarged CEC since |
|---|---|---|
| Claudia Böckstiegel (1964) | General Counsel | 2020 |
| Dr Levi Garraway (1968) | Head of Global Product Development and Chief Medical Officer | 2023 |
| Silke Hörnstein (1975) | Head of Corporate Strategy and Sustainability | 2023 |
| Wafaa Mamilli (1967) | Chief Digital and Technology Officer | 2025 |
| Dr Aviv Regev (1971) | Head of Genentech Research and Early Development (gRED) | 2020 |
| Nina Schwab-Hautzinger (1975) | Head of Group Communications | 2026 |
| Boris L. Zaïtra (1972) | Head of Corporate Business Development | 2024 |
Secretary to the Corporate Executive Committee
| Name (year of birth) | |
|---|---|
| Silke Hörnstein (1975) |
Archive
(CVs as per end of term)
:quality(90)/)
Guidelines for security holdings
According to the guidelines for security holdings, since 2012 members of the Corporate Executive Committee are required to hold Roche securities as outlined in the Annual Report 2025, page 210, 5.14.
Members of the Corporate Executive Committee are now required to hold Roche securities equivalent in value to 200% (previously 100%) of their respective annual base salary. This requirement must be fulfilled within five years from 15 March 2022 or, in the case of new members, within five years from the start of employment.
The requirement of Roche security holdings for the CEO Roche Group remains unchanged at 500% of his annual base salary, without a five-year time limit.
:quality(90)/)